tradmap

MED Earnings MEDIFAST INC

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$2 $6 $14 $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $799M $2B 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$19M $73M $164M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$0 $1 $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
EPS
Revenue (quarterly)
$0 $96M $191M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue
Net income (quarterly)
-$18M -$5M $8M $0 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Net income

Reported EPS history

1–60 of 60
Q3 20262026-09-30-1.572026-10-2610-Q
Q2 20262026-06-30-0.282026-08-0310-Q
Q1 20262026-03-31-0.192026-05-0410-Q
Q4 2025 (derived)2025-12-31-1.642026-02-1710-K
FY 20252025-12-31-1.702026-02-1710-K
Q3 20252025-09-30-0.212025-11-0310-Q
Q2 20252025-06-300.222025-08-0410-Q
Q1 20252025-03-31-0.072025-04-2810-Q
Q4 2024 (derived)2024-12-310.082025-02-1810-K
FY 20242024-12-310.192025-02-1810-K
Q3 20242024-09-300.102024-11-0410-Q
Q2 20242024-06-30-0.752024-08-0510-Q
Q1 20242024-03-310.762024-04-2910-Q
Q4 2023 (derived)2023-12-310.542024-02-2010-K
FY 20232023-12-319.102024-02-2010-K
Q3 20232023-09-302.122023-11-0610-Q
Q2 20232023-06-302.772023-08-0710-Q
Q1 20232023-03-313.672023-05-0110-Q
Q4 2022 (derived)2022-12-312.452023-02-2110-K
FY 20222022-12-3112.732023-02-2110-K
Q3 20222022-09-303.272022-11-0310-Q
Q2 20222022-06-303.422022-08-0310-Q
Q1 20222022-03-313.592022-05-0210-Q
Q4 2021 (derived)2021-12-312.912022-02-2310-K
FY 20212021-12-3113.892022-02-2310-K
Q3 20212021-09-303.562021-11-0410-Q
Q2 20212021-06-303.962021-08-0410-Q
Q1 20212021-03-313.462021-05-0410-Q
Q4 20202020-12-312.362021-02-2610-K
FY 20202020-12-318.682021-02-2610-K
Q3 20202020-09-302.912020-11-0310-Q
Q2 20202020-06-301.862020-08-0610-Q
Q1 20202020-03-311.562020-05-0610-Q
Q4 20192019-12-311.662020-03-0210-K
FY 20192019-12-316.432020-03-0210-K
Q3 20192019-09-301.322019-11-0810-Q
Q2 20192019-06-301.752019-08-0210-Q
Q1 20192019-03-311.702019-05-0210-Q
Q4 20182018-12-311.302019-03-0110-K
FY 20182018-12-314.622019-03-0110-K
Q3 20182018-09-301.142018-11-0710-Q
Q2 20182018-06-301.162018-08-0610-Q
Q1 20182018-03-311.012018-05-0410-Q
Q4 20172017-12-310.602018-03-1610-K
FY 20172017-12-312.292018-03-1610-K
Q3 20172017-09-300.552017-11-0810-Q
Q2 20172017-06-300.632017-08-0910-Q
Q1 20172017-03-310.512017-05-1010-Q
Q4 20162016-12-310.342017-03-1610-K
FY 20162016-12-311.492017-03-1610-K
Q3 20162016-09-300.512016-11-0910-Q
Q2 20162016-06-300.292016-08-0910-Q
Q1 20162016-03-310.362016-05-1010-Q
Q4 20152015-12-310.33——
FY 20152015-12-311.662016-03-1510-K
Q3 20152015-09-300.462015-11-0910-Q
Q2 20152015-06-300.512015-08-1010-Q
Q1 20152015-03-310.362015-05-1110-Q
Q4 2014 (derived)2014-12-31-0.252015-03-1610-K
FY 20142014-12-311.032015-03-1610-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.